KAREN POTTER SANDY: Open Payments
NPI 1144871294 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 38 payments from 10 companies in 2025. Trend: 2023 $257 · 2024 $421 · 2025 $952
Food & beverage: $952
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $266 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $247 |
| Madrigal Pharmaceuticals | 4 | $128 |
| Ardelyx, Inc. | 4 | $84 |
| ABBVIE INC. | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| Braintree Laboratories, Inc. | 2 | $42 |
| Lilly USA, LLC | 1 | $16 |
| Micro-tech Endoscopy USA, Inc. | 1 | $16 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, IBSRELA, RINVOQ, XIFAXAN, EOHILIA, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
